Manuscripts
Showing 1459 manuscripts.
Genetic complexity in the replication-competent latent HIV reservoir increases with untreatedinfection duration in infected youth
Citation
ZL Brumme, H Sudderuddin, C Ziemniak, K Luzuriaga, BR Jones, JB Joy, CK Cunningham, T Greenough, D Persaud. Genetic complexity in the replication-competent latent HIV reservoir increases with untreatedinfection duration in infected youth. AIDS. 2019. 33: 211-218. PMID: 30325763Year
2019
Journal
AIDS
Study
P1059
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
Citation
Jeannie Collins, Kara Wools-Kaloustian, Ruth Goodall, Colette Smith, Elaine Abrams, Suna Balkan, Jihan Ben-Farhat, Mary-Ann Davies, Andrew Edmonds, Valeriane Leroy, Harriet Nuwagaba-Biribonwoha, Kunjal Patel, Mary Paul, Jorge Pinto, Pablo Rojo Conejo, Annette Sohn, Russell Van Dyke, Rachel Vreeman. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.. Lancet HIV. 2019. 6: e105-e115. PMID: 30723008Year
2019
Journal
Lancet HIV
Study
P1074
Adverse Pregnancy Outcomes Among Women who Conceive on Antiretroviral Therapy
Citation
Risa Hoffman, Sean Brummel, Paula Britto, Jose Pilotto, Gaerolwe Masheto, Linda Aurpibul, Esau Joao, Murli Purswani, Shelley Buschur, Marie Flore Pierre, Anne Coletti, Nahida Chakhtoura, Karin Klingman, Judith Currier for the 1077HS PROMISE Team. Adverse Pregnancy Outcomes Among Women who Conceive on Antiretroviral Therapy. Clinical Infectious Diseases. 2019. 68: 273-279. PMID: 29868833Year
2019
Journal
Clinical Infectious Diseases
Study
1077HS
Efavirenz Pharmacokinetics During Pregnancy and Infant Washout
Citation
Regis Kreitchmann, Stein Schalkwijk, Brookie Best, Jiajia Wang, Angela Colbers, Alice Stek, David Shapiro, Tim Cressey, Mark Mirochnick, David Burger for the P1026s Study Team and PANNA Network. Efavirenz Pharmacokinetics During Pregnancy and Infant Washout. Antiviral Therapy. 2019. 24: 95-103. PMID: 30530925Year
2019
Journal
Antiviral Therapy
Study
P1026S
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.
Citation
S Nachman, C Alvero, H Teppler, B Hamony, AJ Rodgers, BL Graham, T Fenton, LM Frenkel, RS Browning, R Hazra, AA Wiznia, IMPAACT 1066 Study Team. Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial.. Lancet HIV. 2018. 5: e715-e722. PMID: 30527329Year
2018
Journal
Lancet HIV
Study
P1066
Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview.
Citation
M Chernoff, KN Angelidou, PL Williams, P Brouwers, M Warshaw, S Nachman, IMPAACT P1055 Study Team. Assessing Psychiatric Symptoms in Youth Affected by HIV: Comparing a Brief Self-Administered Rating Scale with a Structured Diagnostic Interview.. Journal of Clinical Psychology in Medical Settings. 2018. 25: 420-428. PMID: 29460107Year
2018
Journal
Journal of Clinical Psychology in Medical Settings
Study
P1055
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.
Citation
RM Hoffman, KN Angelidou, SS Brummel, F Saidi, A Violari, D Dula, V Mave, L Fairlie, G Theron, M Kamateeka, T Chipato, BH Chi, L Stranix-Chibanda, T Nematadzira, D Moodley, D Bhattacharya, A Gupta, A Coletti, JA McIntyre, KL Kingman, N Chakhtoura, DE Shapiro, MG Fowler, JS Currier, IMPAACT PROMISE 1077BF/FF Team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.. HIV Clinical Trials. 2018. 19: 209-224. PMID: 30890061Year
2018
Journal
HIV Clinical Trials
Study
1077BF, 1077FF
HIV Testing Uptake among Household Contacts of Multidrug-resistant Tuberculosis Index Cases in Eight Countries
Citation
Valarie Opollo, Xingye Wu, Michael Hughes, Susan Swindells, Amita Gupta, Anneke Hesseling, Gavin Churchyard, Soyeon Kim, Richard Lando, Rodney Dawson, Vidya Mave, Alberto Mendoza, Pedro Gonzales, N Kumarasamy, Christelle Van Niekerk, Francesca Conradie, Justin Shenje, Sandy Nerette Fontain, Anthony Garcia-Prats, Aida Asmelash, Tim Cressey, Debra Peters, Rosie Mngqibisa, Ana Cristina Garcia Ferreira, Elisha Okeyo, Linda Naini, Lynne Jones, Betsy Smith, Sarita Shah for the A5300/I2003 study team. HIV Testing Uptake among Household Contacts of Multidrug-resistant Tuberculosis Index Cases in Eight Countries. International Journal of Tuberculosis and Lung Disease. 2018. 1: 1443-1449. PMID: 30606316Year
2018
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Elvitegravir/Cobicistat Pharmacokinetics in Pregnant and Postpartum Women with HIV
Citation
JD Momper, BM Best, J Wang, EV Capparelli, A Stek, E Barr, ML Badell, EP Acosta, M Purswani, E Smith, N Chakhtoura, K Park, S Burchett, DE Shapiro, M Mirochnick, IMPAACT P1026s Protocol Team. Elvitegravir/Cobicistat Pharmacokinetics in Pregnant and Postpartum Women with HIV. AIDS. 2018. 32: 2507-2516. PMID: 30134297Year
2018
Journal
AIDS
Study
P1026S
Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children.
Citation
K Patel, J Lindsey, K Angelidou, G Aldrovandi, P Palumbo, IMPAACT P1060 Study team. Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children.. AIDS. 2018. 32: 2327-2336. PMID: 30102656Year
2018
Journal
AIDS
Study
P1060